4Anderson FA, Wheeler HB, Goldberg R J, et al. A population-based perspective of the hospital incidence and case fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study [J]. Arch Intern Med,1991 ;151 (5) :933-8.
5Remy-Jardin M, Mastora I, Remy J. Pulmonary embolus imaging with muhislice CT[J]. Radiol Clin North Am,2003 ;41 (3) :507-19.
6Samkoff JS, Comtock CW. Epidemiology of pulmonary embolism : mortality in a general population [ J ]. Am J Epidemiol, 1981 ;114 (4) :488.
7Monreal M, Ruiz J, Olazabal A, et al. Deep venous thrombosis and the risk of pulmonary embolism : a systematic study [J]. Chest, 1992 ; 102 : 677-81.
4[1]Dalen JE.Resolution rate of acute pulmonary embolism in man.N Engl J Med,1969,280:1194
5[2]Jerjes - SC,Raminrez - RA,Garcia Ml,et al.Streptokinase and heparin versus heparin alone in massive pulmonary embolism;a randomized controlled trial.J Thromb Thrombolysis,1995,2:227 -9
6[3]Goldhaber SZ,Kessler GM,Heit J,et al.Randomized controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism.Lancet,1988,2:293 - 298
7[4]Goldhaber SZ.Recombinant tissue - type plasminogen activater versus a novel dosing controlled multicenter trial.J Am Coll Cardiol,1992,20( 1 ) :24 - 30
8[5]Goldhober SZ,Aggnelli G,Levine MN.Reduced dose alteplase vs conventional alteplase infution for pulmonary embolism thrombolysis an international multicenter randomized trial.Chest,1994,106:718-724
9[6]Goldhaber SZ,Haire WD,Feldstein ML.Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right - ven-tricular function and pulmonary perfusion.Lancet,1993,341:507 -511
10[7]Jezek V.Thrombolysis in acute pulmonary embolism: to whom,how much and how? Eur Heart J,1997,18:1045
